aspr

FDA Fully Approves the Moderna COVID-19 Vaccine, Second COVID-19 Vaccine to Receive Full FDA Approval

Healthcare providers discussing treatment options

ASPR Begins Distribution of 400 Million N95 Masks from Strategic National Stockpile

The masks are on the move! The first of 400 million N95 masks departed the Strategic National Stockpile last week and are en route to pharmacies and health centers nationwide. In the latest edition of the ASPR Blog, HHS Assistant Secretary for Preparedness and Response Dawn O’Connell talks about how ASPR is increasing access to high-quality masks nationwide and taking other actions to protect the American people from COVID-19.

Read More
healthcare provider typing on computer in office
FDA Fully Approves
the Moderna COVID-19 Vaccine,
Second COVID-19 Vaccine to Receive
Full FDA Approval
Read More
Health care provider inventorying boxes of medicine
DOD, HHS Purchase 380 Million
COVID-19 Test Kits, Supports
President’s Plans to Deliver 500 Million
Free At-home COVID-19 Tests
Read More
Health care provider inventorying boxes of medicine
HHS Renews Public Health Emergency
Declaration for COVID-19
Read the News Release
healthcare provider typing on computer in office
FDA Restricts Use of Bam/Ete and
REGEN-COV; ASPR Pauses Allocation
Read the Full Update
healthcare provider typing on computer in office
ASPR Dawn O’Connell Highlights
COVID-19 Response Progress Before
the U.S. Senate Committee on Health,
Education, Labor and Pensions
Read Dawn’s Priorities
Health care provider inventorying boxes of medicine
NDMS Provides Surge Support
at Upstate Medical University
in Syracuse, NY, Continues to
Deploy Nationwide
Read More
Scientist working in lab
BARDA Seeks Partners to Repurpose
Existing Therapeutics as
Countermeasures To Chemical Threats
(Cyanide, Opioids, Nerve Agents, Etc.)
Apply Today!
medical countermeasure manufacturing equipment
Can Your Organization/Company Help
Strengthen the Supply Chain for
Medical Countermeasure Production,
Manufacturing, and Implementation?
Submit RFI Response
Facebook
Twitter
YouTube
LinkedIn
Instagram